Key result
Enterovirus genome was detected in 35.7% of patients with idiopathic dilated cardiomyopathy and 32.8% of patients with chronic coronary disease, with none detected in healthy controls.
Why the study?
Does enterovirus persist or actively replicate in the cardiac tissue of patients with end-stage ischemic or dilated cardiomyopathy?
Observational (n=179)
Does enterovirus persist or actively replicate in the cardiac tissue of patients with end-stage ischemic or dilated cardiomyopathy?
A small percentage of patients with end-stage chronic cardiac diseases have active enterovirus replication in their myocardium, while the majority of infected patients exhibit latent infection.
Answers are grounded in this paper and cite their sources.
Enterovirus genome in myocardium of chronic cardiomyopathy may reflect latent infection; leaves open its pathogenic role and need for targeted antivirals.
To investigate enterovirus replication versus persistence in end-stage cardiac diseases, endomyocardial biopsies from explanted hearts of 70 patients with idiopathic dilated cardiomyopathy (IDCM), 64 patients with chronic coronary disease (CCD), and 45 donors of healthy hearts (controls) were examined by reverse transcriptase-polymerase chain reaction for genomic and antigenomic enterovirus RNA and by VP1 antigen immunohistochemistry. Enterovirus genome was detected in 25 of 70 patients with IDCM and in 21 of 64 patients with CCDs (35.7 vs. 32.8%, respectively; P=.12). Of the 46 patients positive for genomic RNA, only 3 exhibited antigenomic RNA and VP1 antigen that demonstrated active viral replication, whereas 43 had latent infection characterized by the absence of antigenomic RNA associated with or not with VP1 antigen expression. No viral component was detected in control subjects. The findings demonstrate that a small percentage of patients with end-stage chronic cardiac diseases had active enterovirus replication in their myocardium.
No takes yet. Share an insight, caveat, or question.
Andréoletti et al. (2000) conducted an observational in End-stage ischemic or dilated cardiomyopathy (n=179). Idiopathic dilated cardiomyopathy vs. Chronic coronary disease was evaluated on Detection of enterovirus genome (p=.12). Enterovirus genome was detected in 35.7% of patients with idiopathic dilated cardiomyopathy and 32.8% of patients with chronic coronary disease, with none detected in healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: